Investor Information
Bayer’s share price showed mainly lateral movement in the third quarter, closing on September 30, 2007, at €55.82, up 37.3 percent from the closing price at the end of 2006. Including the dividend of €1.00 per share for 2006 paid on April 30, 2007, Bayer stock achieved a performance of 40.0 percent in the first nine months of 2007. Over the same period the DAX rose 19.2 percent to 7862 points.
The delisting of Bayer’s American Depositary Shares (ADSs) from the New York Stock Exchange (NYSE) was completed on September 27, 2007. Since then, Bayer ADSs have been traded in the U.S. over-the-counter market. The company has also filed for deregistration with the Securities and Exchange Commission (SEC) on Form 15-F.
Bayer has applied the International Financial Reporting Standards (IAS/IFRS) of the International Accounting Standards Board (IASB) since 1994. We will maintain the transparency of our financial reporting irrespective of the intended deregistration with the SEC and the resulting termination of the respective reporting obligations.
The delisting of Bayer’s American Depositary Shares (ADSs) from the New York Stock Exchange (NYSE) was completed on September 27, 2007. Since then, Bayer ADSs have been traded in the U.S. over-the-counter market. The company has also filed for deregistration with the Securities and Exchange Commission (SEC) on Form 15-F.
Bayer has applied the International Financial Reporting Standards (IAS/IFRS) of the International Accounting Standards Board (IASB) since 1994. We will maintain the transparency of our financial reporting irrespective of the intended deregistration with the SEC and the resulting termination of the respective reporting obligations.
| Bayer Stock Key Data | 3rd Quarter 2006 | 3rd Quarter 2007 | First Nine Months 2006 | First Nine Months 2007 | |
| High for the period | € | 40.20 | 58.56 | 40.20 | 58.56 |
| Low for the period | € | 35.32 | 50.33 | 30.56 | 40.20 |
| Average daily share turnover on German stock exchanges | million | 5.1 | 6.0 | 6.0 | 5.9 |
Sept. 30, 2006 | Sept. 30, 2007 | Dec. 31, 2006 | Change Sept. 30, 2007/ Dec. 31, 2006 % | ||
| Share price | € | 40.20 | 55.82 | 40.66 | 37.3 |
| Market capitalization | € million | 30,727 | 42,665 | 31,078 | 37.3 |
| Stockholders’ equity | € million | 13,164 | 17,008 | 12,851 | 32.3 |
| Number of shares entitled to the dividend | million | 764.34 | 764.34 | 764.34 | 0.0 |
| DAX | 6004 | 7862 | 6597 | 19.2 |
XETRA closing price; source: Bloomberg
Index (100 = XETRA closing price on December 31, 2005)

Fidelity Management and Research LLC. (a Delaware limited liability company with its principal place of business at Boston, Massachusetts, USA) has informed us that, as a result of an internal merger reorganization effective October 1, 2007, it became the successor entity to Fidelity Management and Research Corp. and has assumed all that company’s rights and obligations. It has notified us that the proportion of voting rights it held in our company exceeded the 3 percent threshold on October 1, 2007, that as of that date it held 4.71 percent of the voting rights, and that the shares/voting rights were to be attributed to Fidelity Management and Research LLC., United States, pursuant to Section 22, Paragraph 1, Sentence 2 in conjunction with Section 22, Paragraph 1, Sentence 1, No. 6 of the German Securities Trading Act. Any notification received from other shareholders as to whether the proportion of voting rights they hold in our company exceeds or falls below specified thresholds is detailed on our website at: www.investor.bayer.com/en/aktie/aktionaersstruktur/stimmrechtsanteile/
Earnings per share according to IFRS are affected by the purchase price allocation for Schering, Berlin, Germany, and other special factors. To enhance comparability, we also determine core net income from continuing operations after elimination of the amortization of intangible assets, asset write-downs (including any impairment losses), special items in EBITDA including the related tax effects, and extraordinary tax income or expense.
The €0.9 billion in one-time non-cash tax income received in the third quarter of 2007 in connection with the German corporate tax reform represents a special tax effect and is therefore eliminated.
The calculation of earnings per share in accordance with IFRS is explained in the notes to this interim report. Adjusted core net income, core earnings per share and core EBIT are not defined in the International Financial Reporting Standards. Therefore they should be regarded as supplementary information rather than stand-alone indicators.
The €0.9 billion in one-time non-cash tax income received in the third quarter of 2007 in connection with the German corporate tax reform represents a special tax effect and is therefore eliminated.
The calculation of earnings per share in accordance with IFRS is explained in the notes to this interim report. Adjusted core net income, core earnings per share and core EBIT are not defined in the International Financial Reporting Standards. Therefore they should be regarded as supplementary information rather than stand-alone indicators.
| Calculation of Core EBIT and Core Earnings per Share | 3rd Quarter 2006 | 3rd Quarter 2007 | First Nine Months 2006 | First Nine Months 2007 |
| € million | ||||
| EBIT as per income statement | 630 | 677 | 2,556 | 2,769 |
| Amortization and write-downs of intangible assets | 189 | 479 | 467 | 1,097 |
| Write-downs of property, plant and equipment | 23 | 9 | 29 | 86 |
| Special items (other than write-downs) | 335 | 120 | 497 | 570 |
| Core EBIT | 1,177 | 1,285 | 3,549 | 4,522 |
| Non-operating result (as per income statement) | (267) | (266) | (705) | (741) |
| Extraordinary income/loss from investments in affiliated companies | - | - | - | - |
| Income taxes (as per income statement) | (109) | 769 | (584) | 221 |
| One-time tax income* | 0 | (911) | 0 | (911) |
| Tax adjustment | (195) | (234) | (351) | (617) |
| Income after taxes attributable to minority interest (as per income statement) | 0 | (3) | 0 | (1) |
| Core net income from continuing operations | 606 | 640 | 1,909 | 2,473 |
| Financing expenses for the mandatory convertible bond, net of tax effects | 25 | 25 | 48 | 73 |
| Adjusted core net income | 631 | 665 | 1,957 | 2,546 |
| Shares | ||||
| Weighted average number of issued ordinary shares | 760,276,703 | 764,341,920 | 740,429,832 | 764,341,920 |
| Potential shares to be issued upon conversion of the mandatory convertible bond | 60,115,244 | 59,585,493 | 41,299,096 | 59,558,606 |
| Adjusted weighted average total number of issued and potential ordinary shares | 820,391,947 | 823,927,413 | 781,728,928 | 823,900,526 |
| Core earnings per share from continuing operations (€) | 0.77 | 0.81 | 2.50 | 3.09 |
2006 figures restated
* arising from the corporate tax reform in Germany
* arising from the corporate tax reform in Germany

Overview of Sales, Earnings and Financial Position
Bayer Links

Bookmark this page
E-mail this page
Advanced Search

